🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ovarian cancer is the leading cause of death from gynecologic tumors in the...
Status
Recruiting
Location
Women's Hospital School Of Medicine Zhejiang University
Start Date
2020-07-01
Trial ID
NCT04518501
Treatments Being Tested
This study is a randomized, open-label, double-cohort, national multi-cente...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-30
Trial ID
NCT07355010
Treatments Being Tested
In this study, investigators propose to use fuzuloparib and apatinib as neo...
Status
Recruiting
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2025-06-25
Trial ID
NCT07033819
To evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P ...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology LLC
Start Date
2021-03-18
Trial ID
NCT04691804
This study is an open label, single arm, multicenter clinical trial. The ai...
Status
Recruiting
Location
The First Affiliated Hospital of China Medical University
Start Date
2024-11-27
Trial ID
NCT06971211
Thirty-seven women aged 18-75 years with recurrent ovarian cancer were enro...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-01
Trial ID
NCT06188455
Treatments Being Tested
To investigate the efficacy and safety of Retlirafusp alfa in combination w...
Status
Not Yet Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2026-07-30
Trial ID
NCT07752550
The study will be a Prospective, Single-arm, Phase Ⅱ Clinical Study. This s...
Status
Unknown
Location
Fudan University Shanghai Cancer Cente
Start Date
2023-04-30
Trial ID
NCT05819060
Treatments Being Tested
This study evaluates the efficacy and safety of Zeprumetostat in combinatio...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-04
Trial ID
NCT07339553
Treatments Being Tested
The investigators explore the efficacy and safety of adebrelimab (PD-L1 inh...
Status
Not Yet Recruiting
Location
Fujian Cancer Hospital
Start Date
2024-10-01
Trial ID
NCT06600841
Treatments Being Tested